Publications
487
Citations
35,263
Est. group size
~41
Recurring co-author estimate
Active years
47
Publishing since 1980
Michael R. Grever's research centers on hairy cell leukemia and related blood cancers, focusing on clinical treatment approaches such as purine analog drugs, targeted BRAF inhibitors, and combination salvage therapies for patients who relapse. His work also examines drug side effects, dosing strategies, and updated clinical guidelines for diagnosing and managing this disease. This research is primarily clinical and translational, aimed at improving treatment outcomes for patients with this rare blood cancer.
Publication output has grown substantially over the last decade, rising from roughly 9 papers per year in 2017 to a peak of 38 in 2023, though it has declined again in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Two-inhibitor salvage therapy for hairy cell leukemia
Blood · 2023
- Clinical Development of 2′-Deoxycoformycin
2021
- The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant
British Journal of Haematology · 2020
- Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies
British Journal of Clinical Pharmacology · 2019
- Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia
International Journal of Dermatology · 2018
- Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues
Journal of the American Academy of Dermatology · 2018
- Acquired Resistance to BRAF Inhibition in Hcl Is Rare and Retreatment with Vemurafenib at Relapse Can Induce High Response Rates: Final Results of a Phase II Trial of Vemurafenib in Relapsed Hcl
Blood · 2018
- Biomedical Science Undergraduate Major: A New Pathway to Advance Research and the Health Professions
Teaching and Learning in Medicine · 2017
- BRAF inhibitor: targeted therapy in hairy cell leukemia
Blood · 2016
- Blood×43
- Leukemia×10
- Journal of Clinical Oncology×9
- Blood Advances×6
- American Journal of Hematology×4
- Margaret S. Lucas
Medicine · The Ohio State University
- John C. Byrd
Medicine · The Ohio State University
- Cecelia Miller
Medicine · The Ohio State University
- Kerry A. Rogers
Medicine · The Ohio State University
- John C. Byrd
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile